You are here

  • Home
  • Archive
  • Volume 3, Issue 3
  • Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India

Article info

Article menu

Download PDFPDF

XML
Research
Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India

Authors

  • Itamar Megiddo Department of Management Science, University of Strathclyde, Glasgow, UK Center for Disease Dynamics Economics and Policy, Washington, District of Columbia, USA PubMed articlesGoogle scholar articles
  • Eili Klein Center for Disease Dynamics Economics and Policy, Washington, District of Columbia, USA Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Ramanan Laxminarayan Department of Management Science, University of Strathclyde, Glasgow, UK Center for Disease Dynamics Economics and Policy, Washington, District of Columbia, USA Princeton Environmental Institute, Princeton University, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Itamar Megiddo; itamar.megiddo{at}strath.ac.uk
View Full Text

Citation

Megiddo I, Klein E, Laxminarayan R
Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India
BMJ Global Health 2018;3:e000636.

Publication history

  • Received November 3, 2017
  • Revised February 16, 2018
  • Accepted March 29, 2018
  • First published May 9, 2018.
Online issue publication 
May 01, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/